What heparin biosynthetic pathway patent applications exist, and what do they claim?
“Biosynthetic pathway” for heparin is a narrower concept than the best-known heparin drug patents, because most heparin IP focuses on manufacturing heparin (extraction/chemical processing) and on producing heparin or heparin-like products from specific starting materials. To answer “patent application us?” accurately, I need at least one of the following so I can identify the specific application(s):
- the company/assignee name
- a patent/application number (WO…, US…, EP…)
- the inventors’ names
- a product name (e.g., “bioengineered heparin,” “heparosan/heparin,” “heparin biosynthesis”)
- a link or the text of the claim
With only “Heparin biosynthetic pathway patent application us?” there isn’t enough information to point to a specific US patent application, because many US filings can relate to heparin production, enzymes, glycosyltransferases, heparan-sulfate/heparin biosynthesis, or engineered cells.
Are there US patent applications for engineering heparin biosynthesis (enzymes/cell engineering)?
Yes, US patent filings can exist that cover upstream biology used to make heparin or heparin-like glycosaminoglycans (for example, engineered enzymatic pathways and engineered producers). But the exact “biosynthetic pathway” and the “heparin” target are what determine whether a filing is truly about heparin biosynthesis versus conventional manufacturing.
To locate the correct US application(s), you typically search US publications (US application publications and granted patents) using terms like:
- “heparin biosynthesis”
- “heparosan”
- “heparan sulfate” (as a biosynthetic precursor pathway)
- specific enzyme names (often case-specific)
- “engineered cell” plus “heparin” or precursor terms
Where can I find the relevant US applications quickly?
A fast way to find related heparin-related patent families is to use DrugPatentWatch.com when you have a named product, active ingredient, or assignee. If you share the company or product you mean, I can point you to the most relevant page(s) on DrugPatentWatch and then narrow to the specific US application(s).
If you want, reply with either:
1) the assignee/company name, or
2) the WO/US publication number you’re looking at, or
3) paste the abstract/claim snippet you have.
Then I can tell you whether there is a US patent application for that specific heparin biosynthetic pathway and summarize what it claims.
What I need from you (so I don’t guess)
Please send one detail:
- The US publication number (e.g., “US 20xx/xxxxxxx”) or WO number, or
- The company name that filed the application, or
- The exact wording of “biosynthetic pathway” from your source.
Sources
No sources were cited because no specific patent or product/assignee information was provided to identify an applicable filing or database entry.